Evaluation of Imipenem for Prophylaxis and Therapy of Yersinia pestis Delivered by Aerosol in a Mouse Model of Pneumonic Plague
Open Access
- 1 June 2014
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (6) , 3276-3284
Abstract
It has been previously shown that mice subjected to an aerosol exposure to Yersinia pestis and treated with β-lactam antibiotics after a delay of 42 h died at an accelerated rate compared to controls. It was hypothesized that endotoxin release in antibiotic-treated mice accounted for the accelerated death rate in the mice exposed to aerosol Y. pestis. Imipenem, a β-lactam antibiotic, binds to penicillin binding protein 2 with the highest affinity and produces rounded cells. The binding of imipenem causes cells to lyse quickly and thereby to release less free endotoxin. Two imipenem regimens producing fractions of time that the concentration of free, unbound drug was above the MIC (fT>MIC) of approximately 25% (6/24 h) and 40% (9.5/24 h) were evaluated. In the postexposure prophylaxis study, the 40% and 25% regimens produced 90% and 40% survivorship, respectively. In the 42-h treatment study, both regimens demonstrated a 40 to 50% survivorship at therapy cessation and some deaths thereafter, resulting in a 30% survivorship. As this was an improvement over the results with other β-lactams, a comparison of both endotoxin and cytokine levels in mice treated with imipenem and ceftazidime (a β-lactam previously demonstrated to accelerate death in mice during treatment) was performed and supported the original hypotheses; however, the levels observed in animals treated with ciprofloxacin (included as an unrelated antibiotic that is also bactericidal but should cause little lysis due to a different mode of action) were elevated and significantly (7-fold) higher than those with ceftazidime.Keywords
This publication has 29 references indexed in Scilit:
- Natural History of Yersinia pestis Pneumonia in Aerosol-Challenged BALB/c MiceAntimicrobial Agents and Chemotherapy, 2013
- TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plagueVaccine, 2010
- Population Pharmacokinetics and Pharmacodynamics of Continuous versus Short-Term Infusion of Imipenem-Cilastatin in Critically Ill Patients in a Randomized, Controlled TrialAntimicrobial Agents and Chemotherapy, 2007
- Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide responseNature Immunology, 2006
- Gamma Interferon, Tumor Necrosis Factor Alpha, and Nitric Oxide Synthase 2, Key Elements of Cellular Immunity, Perform Critical Protective Functions during Humoral Defense against Lethal PulmonaryYersinia pestisInfectionInfection and Immunity, 2006
- Temperature-Dependent Variations and Intraspecies Diversity of the Structure of the Lipopolysaccharide of Yersinia pestis,Biochemistry, 2005
- Genetic Variability of Yersinia pestis Isolates as Predicted by PCR-Based IS 100 Genotyping and Analysis of Structural Genes Encoding Glycerol-3-Phosphate Dehydrogenase ( glpD )Journal of Bacteriology, 2002
- High prevalence of ciprofloxacin resistance amongst strains of Neisseria gonorrhoeae isolated from commercial sex workers in BangladeshJournal of Antimicrobial Chemotherapy, 1998
- Multidrug Resistance inYersinia pestisMediated by a Transferable PlasmidNew England Journal of Medicine, 1997
- Interleukin-10Annual Review of Immunology, 1993